Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Abrocitinib may effectively treat Lichen Planopilaris.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

JAK inhibitors show promise in treating difficult skin diseases.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

A(1-7) treatment reduces symptoms of lupus in mice.

Letrozole may help prevent seizures by reducing certain hormone levels.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.